Corporate Member Roster

Scroll down to see the full list of our prestigious corporate members! 

 

               PlatCorpMem       
   Astrazeneca Logo   Bayer Updated Logo Feb 2019    Celgene
 

  
 
                   PlatGenentechLogo     Gilead logo      GSK Logo Final   
                  NovoNordisk                                            sandoz logo final     Takeda Final 
           
           PlusCorpMem       
    
 amgen logo  
 Alnylam Logo 
  
AveXis Logo

 
  
   Dexcom     Harmony Hi Res     Indivior Logo   
      

Ipsen logo 
   Johnson and Johnson Mar 2018 
  
  Myriad 


 
 
 Relypsa logo resized
 
    Sobi logo       
     

ClickHereClick here for details on corporate membership levels. 
     
                 




   Abarca Health LLC

 
www.abarcahealth.com

We are a different kind of PBM and a different kind of company. Our entire organization has a culture of accountability, a sense of urgency, and an unstoppable commitment to finding a better way.  Abarca has deep experience serving public and private sector organizations, including: Medicare and Commercial Health Plans, Self Insured Employers, State Medicaid Programs, and Large Insurers and PBMs.  Americans are spending nearly half a trillion dollars every year on prescription benefits. It’s a system that isn’t working for payers, members, or providers. It doesn’t need to be this way. We believe costs should be lower, hassles should be fewer, and the experience should be better. And with a smarter technology and a straightforward approach to business, we are ready to lead the way.
 


   Abbvie

 
www.abbvie.com

AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. Together with its wholly-owned subsidiary, Pharmacyclics, AbbVie employs more than 28,000 people worldwide and markets medicines in more than 170 countries. For further information on the company and its people, portfolio and commitments, please visit www.abbvie.com. Follow @abbvie on Twitter or view careers on our Facebook or LinkedIn page.
 


   ACADIA Pharmaceuticals Inc.

 
www.acadia-pharm.com

At ACADIA (NASDAQ: ACAD), we share a passion for improving the lives of patients with central nervous system (CNS) disorders. Our vision is to become the leading pharmaceutical company dedicated to the advancement of innovative medicines that improve the lives of patients with CNS disorders. Our history is rooted in science and strong leadership in CNS research. We have set ourselves apart by transforming our novel discoveries into important drug candidates that may make a meaningful impact on the lives of patients and the family members who care for them every day.
 


   Acorda Therapeutics, Inc.

 
www.acorda.com

Acorda Therapeutics is a biotechnology company developing therapies for spinal cord injury, multiple sclerosis and related nervous system disorders. The Company's marketed products include Zanaflex Capsules® (tizanidine hydrochloride), a short-acting drug for the management of spasticity. Acorda filed a New Drug Application (NDA) for its lead clinical product, Fampridine-SR, on January 30, 2009. Clinical trials of Fampridine-SR evaluated its safety and efficacy in improving walking ability in people with MS. The Company's pipeline includes a number of products in development for the treatment, regeneration and repair of the spinal cord and brain.
 


   ALK Inc.

 
www.alk.net

As a world leader in allergy immunotherapy, ALK works to improve quality of life for the many allergy sufferers whose disease remains uncontrolled despite the use of symptom-relieving medication, by developing products that provide long-lasting relief. The company has approximately 2,000 employees, with subsidiaries, production facilities and distributors worldwide. ALK is headquartered in Denmark and listed on NASDAQ Copenhagen (OMX: ALK B).
 


   Alkermes

 
www.alkermes.com

Alkermes is a fully integrated biopharmaceutical company that applies its scientific expertise and technological know-how to develop innovative medicines designed to yield better therapeutic outcomes for patients with central nervous system (CNS) disorders, including addiction, schizophrenia and depression.
 


   Allergan PLC

 
www.allergan.com

Allergan, Inc. is a global specialty pharmaceutical company that develops and commercializes innovative products for the eye care, neuromodulator, skin care, obesity and other specialty markets. In addition to its discovery-to-development research programs, Allergan has global marketing and sales capabilities in over 100 countries that deliver value to our customers, satisfy unmet medical needs and improve people’s lives. Driven by technology and innovation, Allergan addresses the needs of consumers across the world with over 8,000 employees worldwide, 4 world-class Research and Development facilities and 5 state-of-the-art manufacturing plants.
 


    Alnylam - Corporate Member Plus

 
 www.alnylam.com

Alnylam is leading the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of patients who have limited or inadequate treatment options. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach for the treatment of a wide range of debilitating diseases with high unmet medical need. Alnylam was founded in 2002 on a bold vision to turn scientific possibility into reality, which is now marked by its robust discovery platform and deep pipeline of investigational medicines, including 4 programs in late-stage clinical development. 


   Amarin Pharma, Inc.

 
www.amarincorp.com

Amarin Corporation plc is a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health. Amarin’s product development program leverages its extensive experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. Amarin's clinical program includes commitment to providing grants to support research and education in the disease state including the funding of an ongoing outcomes trial. Vascepa® (icosapent ethyl), Amarin’s first FDA approved product, is a highly-pure, EPA-only, omega-3 fatty acid product availably by prescription. For more information about Vascepa visit www.vascepa.com. For more information about Amarin visit www.amarincorp.com.

 
         


   Amgen, Inc. - Corporate Member Plus

 
www.amgen.com

 Amgen is one of the world’s leading biotechnology companies. Amgen is a values-based company, deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious illnesses.The world’s largest biotechnology company, Amgen Inc. discovers, develops, and delivers important human therapeutics based on advances in cellular and molecular biology including EPOGEN® (Epoetin alfa), Aranesp® (darbepoetin alfa), NEUPOGEN® (Filgrastim), Neulasta® (pegfilgrastim), Enbrel® (etanercept), Kineret® (anakinra) and Sensipar® (cinacalcet HCl). Amgen’s dedication to science and innovation is driven by a commitment to serving patients.
 


   Apobiologix, a division of ApoPharma USA

 
www.apobiologix.com 

Traditional companies focus their innovative efforts on the discovery of new drugs that save and improve lives.  Apobiologix sees a need to go further: to create sustainable health care that doesn't sacrifice quality or patient support. That's why biosimilars also require innovation.Apobiologix is focused on the development of biosimilars that combine the quality and value you need with the level of comprehensive support you expect.  Because at Apobiologix, we don't believe that innovation stops at invention.


   Astellas Pharma US, Inc.

 
www.astellas.com

Launched in April 2005, Astellas was formed by the historical merger of Japan’s third and fifth largest pharmaceutical companies- Yamanouchi, founded in 1923, and Fujisawa, founded in 1894. Created from a partnership of two respected, leading global companies, Astellas is built on a strategic platform focused in select therapeutic areas: Cardiology, Dermatology, Immunology, Infectious Disease, Oncology and Urology. Within each therapeutic area, Astellas focuses on unsurpassed science and building networks of trust among physicians, patients and partners. Key strategic products include: Prograf, VESIcare, Lexiscan, Adenoscan, Protopic, Amevive, AmBisome and Mycamine.
 


   AstraZeneca - Corporate Member Platinum

 
www.astrazeneca.com

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in three therapy areas – Oncology, Cardiovascular & Metabolic Diseases and Respiratory. The Company also is selectively active in the areas of autoimmunity, neuroscience and infection. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information, please visit www.astrazeneca-us.com and follow us on Twitter@AstraZenecaUS.


   Avalere Health, LLC

 
www.avalere.com

Avalere Health is a strategic advisory company whose core purpose is to create innovative solutions to complex healthcare problems. Based in Washington, D.C., the firm delivers actionable insights, business intelligence tools and custom analytics for leaders in healthcare business and policy. Avalere's experts span 230 staff drawn from Fortune 500 healthcare companies, the federal government (e.g., CMS, OMB, CBO and the Congress), top consultancies and nonprofits. The firm offers deep substance on the full range of healthcare business issues affecting the Fortune 500 healthcare companies. Avalere's focus on strategy is supported by a rigorous, in-house analytic research group that uses public and private data to generate quantitative insight. Through events, publications and interactive programs, Avalere insights are accessible to a broad range of customers. For more information, visit avalere.com, or follow us on Twitter @avalerehealth.
 


    Aventine Consulting, LLC

 
www.aventine-consulting.com

Aventine is a consulting firm specializing in the development of formulary submission dossiers and economic modeling and comprised of a strategic team of highly experienced managed care clinicians who understand the needs of the payer audience. Our team leverages our past professional experience on the payer side of the access equation to create dossiers and models that are fit for purpose. We develop scientifically-sound, evidence-based, high-quality deliverables supporting the true value of our clients’ products and have decades of experience communicating to the US payer audience. Our team prides itself on the integrity of our work, the trusted relationships we have forged with our clients, and our high rate of returning customers. Since Aventine’s inception in 2008, our strong reputation as a personable and accountable boutique consulting firm has become one of our greatest professional assets. Ask around – our active client base includes companies of all sizes: from small start-ups, to biotechs, to large pharma companies in the top 5 by global sales revenue. For more information about our services and professional experience, please visit aventine-consulting.com.
 


    AveXis - Corporate Member Plus

 
 www.avexis.com

ADVANCING GENE THERAPY WITH PATIENTS IN MIND -- Rare diseases don't feel rare to the families devastated by them. They create daily challenges that must be faced head-on, often without the help of readily available treatment.  We are making progress in rare and life-threatening neurological genetic diseases—including spinal muscular atrophy (SMA) Type 1 and Type 2, Rett syndrome (RTT) and a genetic form of amyotrophic lateral sclerosis (ALS). Our initial product candidate, AVXS-101, is our proprietary gene therapy currently in development for the treatment of SMA Type 1, the leading genetic cause of infant mortality, and SMA Type 2.
 


   Bayer - Corporate Member Platinum

 
www.bayer.com

Bayer is a Life Science company with a more than 150-year history and core competencies in the areas of health care and agriculture. With our innovative products, we are contributing to finding solutions to some of the major challenges of our time.

At Pharmaceuticals, our largest segment in terms of sales, we focus on researching, developing and marketing specialty-focused innovative medicines that provide significant clinical benefit and value, primarily in the therapeutic areas of cardiology, oncology, gynecology, hematology and ophthalmology. In this way, we are addressing the growing requirements of patients, physicians, health care payers and regulatory agencies.

Science for a Better Life 


   Becton Dickinson & Co.

 
 www.bd.com

BD is a leading global medical technology company that serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. BD manufactures and sells a broad range of medical supplies, devices, laboratory equipment and diagnostic products. The company focuses strategically on achieving growth in three worldwide business segments - BD Medical, BD Diagnostics and BD Biosciences.  BD employs approximately 29,000 associates worldwide in 212 locations in 50 countries.  For the fiscal year ended September 30, 2010, BD's revenues rose to $7.372 billion. BD was founded as a partnership in 1897 and incorporated in 1906. BD became a publicly held company in 1962. The stock is traded on the New York Stock Exchange with the symbol BDX.   BD is dedicated to producing solutions - and the best solution of all is reflected in its corporate purpose, helping all people live healthy lives.

 


   Biogen

 
www.biogen.com

Through cutting-edge science and medicine, Biogen discovers, develops and delivers to patients worldwide innovative therapies for the treatment of neurodegenerative diseases, hematologic conditions and autoimmune disorders. Founded in 1978, Biogen is one of the world’s oldest independent biotechnology companies and patients worldwide benefit from its leading multiple sclerosis and innovative hemophilia therapies. For product labeling, press releases and additional information about the company, please visit www.biogen.com.
 


   Bioventus LLC

 
www.bioventusglobal.com

Our mission is to partner with the health care community to help people resume and enjoy active lives. To this end, we develop and/or market clinically proven and cost-effective orthobiologic solutions for bone fusion and osteoarthritis that are backed by clinical data. Thousands of physicians worldwide view their Bioventus representative as an extension of their practices, trusting them with helping in their patients’ care program and alleviating some of their administrative burdens. Bioventus’ adherence to high quality standards, its commitment to evidence-based medicine and its strong ethical behavior makes the company a trusted partner.
 


   Boehringer Ingelheim Pharmaceuticals, Inc.

 
www.boehringer-ingelheim.com

The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 145 affiliates and more than 44,000 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel medications of high therapeutic value for human and veterinary medicine. As a central element of its culture, Boehringer Ingelheim has a demonstrated commitment to corporate social responsibility. Involvement in social projects, caring for employees and their families, and providing equal opportunities for all employees form the foundation of the global operations. Mutual cooperation and respect, as well as environmental protection and sustainability are intrinsic factors in all of Boehringer Ingelheim’s endeavors. In 2011, Boehringer Ingelheim achieved net sales of about $17.1 billion (13.2 billion euro). R&D expenditure in the business area Prescription Medicines corresponds to 23.5% of its net sales. For more information, please visit http://us.boehringer-ingelheim.com and follow us on Twitter at http://twitter.com/boehringerus.
 


   Bristol-Myers Squibb Company

 
www.bms.com

Our company’s mission is to extend and enhance human life by providing the highest-quality pharmaceutical and related health care products. We pledge – to our patients and customers, to our employees and partners, to our shareholders and neighbors, and to the world we serve – to act on our belief that the priceless ingredient of every product is the honor and integrity of its maker. Aligned with our mission, Bristol-Myers Squibb Managed Markets team is dedicated to supporting the important role managed care plays in extending and enhancing human life.
 


   Celgene - Corporate Member Platinum

 
www.celgene.com

Celgene is a global integrated biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies designed to treat cancer and immunoinflammatory diseases. Celgene is dedicated to work closely with health care providers to assure patients in need have safe access to our drugs. The Company is also proud of the important benefits that our therapies bring to patients, of the Company’s demonstrated commitment to rapidly advance its promising new therapies through development so many more patients can be helped, and of the breadth of its programs to ensure that no American is denied access as a result of lack of resources. The ongoing development of our broad and deep proprietary pipeline of immunomodulatory agents (IMiDs®), cell-signaling inhibitors, as well as cellular and tissue therapeutics may allow Celgene to provide physicians worldwide with a more comprehensive and integrated set of therapeutic solutions for managing complex human diseases.
 


   Chiesi USA

 
www.chiesiusa.com

Chiesi USA is a specialty pharmaceutical company committed to research, development, production and commercialization of innovative products in the areas of cardiovascular, respiratory, neonatology, rare disease and special care therapeutics. Our primary focus is on people: the people we serve in the healthcare community; the people whose lives are touched by our products and services; and the people who work at Chiesi USA, as they strive to build their company, their family and their community.
 


   Collegium Pharmaceutical, Inc.

 
www.collegiumpharma.com

Collegium is a specialty pharmaceutical company focused on developing a portfolio of products that incorporate its patent-protected DETERx technology platform for the treatment of chronic pain and other diseases. The DETERx oral drug delivery technology is designed to provide extended-release delivery, unique abuse-deterrent properties, and flexible dose administration options. Collegium’s lead product candidate, Xtampza ER, is an abuse-deterrent, extended-release, oral formulation of oxycodone, in development for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. Collegium developed Xtampza using its proprietary DETERx technology platform to address common methods of abuse, including chewing, crushing and/or dissolving, and then taking it orally or snorting or injecting.
 


   Conduent

 
www.conduent.com

As the world’s largest business process services company, we’re improving the way businesses and governments interact with their citizens, patients, customers and employees. Our mission is to modernize the constituent experience by making every interaction digital, personalized and secure. Every day we engage in relentless pursuit of greater solutions. We make a difference in the lives of millions every day. 
 


   CVS Health

 
www.cvshealth.com

CVS is headquartered in Woonsocket, RI, the largest pharmacy health care provider in the U.S. and has integrated offerings across the spectrum of pharmacy care that involves more than 246,000 colleagues across all 50 states, Washington, D.C., Puerto Rico and Brazil.  Millions of times a day, we’re helping people on their path to better health—from advising on prescriptions to helping manage chronic and specialty conditions. Because we’re present in so many moments, big and small, we have an active, supportive role in shaping the future of health care.

 


   Daiichi Sankyo, Inc.

 
www.dsi.com

Daiichi Sankyo, Inc., headquartered in Parsippany, New Jersey, is the U.S. subsidiary of Japan-based Daiichi Sankyo Co., Ltd., one of the twenty largest pharmaceutical companies in the world and a global leader in pharmaceutical innovation since 1899. The company is dedicated to the discovery, development and commercialization of innovative medicines that improve the lives of patients throughout the world. The primary focus of Daiichi Sankyo’s research and development is cardiovascular disease, including therapies for dyslipidemia, hypertension, diabetes, and acute coronary syndrome. The company is also pursuing the discovery of new medicines in the areas of glucose metabolic disorders, infectious diseases, cancer, bone and joint diseases, and immune disorders. For more information, visit www.dsus.com.
 

   Dexcom Inc. - Corporate Member Plus

 
 www.dexcom.com

Founded in 1999, Dexcom, Inc. is transforming diabetes care and management by providing superior continuous glucose monitoring (CGM) technology to help patients and healthcare professionals better manage diabetes. Since our inception, we have focused on better outcomes for patients, caregivers, and clinicians by delivering solutions that are best in class—while empowering our community to take control of diabetes
 


     DST Pharmacy Solutions

 
www.dstsystems.com

DST Pharmacy Solutions helps health plans optimize the value in pharmacy benefits and improve clinical outcomes for their members, improve financial performance, reduce administrative burdens, and manage compliance requirements.  Our flexible administrative platform supports and operationalizes all plan types including Commercial, Medicare, Medicaid, and HIM plans, which helps to reduce the resources needed to manage multiple systems, data silos, and vendors.   Our deep experience in data management and advanced analytics combine with clinical expertise to create convergent solutions that  help transform and support coordinated care models and improve physician, pharmacy, and member alignment.


   Eisai, Inc.

 
www.eisai.com 

Satisfying diverse healthcare needs around the world  Around the world there are still many diseases for which no effective treatments exist and many patients who do not have adequate access to the medicines they need. As a global pharmaceutical company addressing these unmet medical needs, Eisai is committed to making contributions to better healthcare for patients and their families around the world through its business activities.

 
 

  EVERSANA

 

 www.eversana.com

We set our sight on a simple, but powerful vision to advance life science services toward a healthier world.  The journey began when Water Street Healthcare Partners and JLL Partners joined forces to acquire and combine the most comprehensive platform of life sciences services in the industry. Together, we are EVERSANA.  We offer more than 500 clients – from start-ups to established global pharmaceutical leaders – the services they need to bring critical therapies to market while improving the lives of patients around the world.  


   Exelixis, Inc.

 
www.exelixis.com

Exelixis, Inc., from the Greek word for “evolution,” is a biopharmaceutical company committed to developing and commercializing small molecule therapies with the potential to improve the treatment of cancer. Over the past decade, we have established a broad development platform, laying the foundation for our continued efforts to bring new therapies for cancer to patients in need. The history of our lead compounds, cabozantinib and cobimetinib, tells the story of our evolution as a company. Each of these compounds were discovered in our own laboratories and advanced by us into clinical development. Exelixis was founded and incorporated in 1994 and we are based in South San Francisco, California. Exelixis is dedicated to improving the care of, and outcomes for patients with cancer.
 


   Genentech Inc. - Platinum Corporate Member

 
www.gene.com

Genentech, Inc. is a leading biotechnology company focusing on the discovery, development, manufacture, and marketing of pharmaceuticals for significant, unmet medical needs. Genentech’s managed care specialists are committed to enhancing the quality and delivery of patient care by working with managed care organizations to find effective solutions to health care issues.
 


   Gilead Sciences, Inc. - Platinum Corporate Member

 
www.gilead.com

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia. Visit Gilead on the World Wide Web at www.gilead.com.
 


   GSK - Corporate Member Platinum

 
www.gsk.com

GlaxoSmithKline (GSK), one of the world’s leading research-based health care companies, discovers, develops, manufactures and markets pharmaceuticals, vaccines, over-the-counter medications and health-related products. GSK’s people are committed to fighting disease by bringing innovative medicines and services to patients throughout the world and to the health care providers who serve them.
 


   Harmony Biosciences - Corporate Member Plus 

 
 www.harmonybiosciences.com

Harmony Biosciences is an innovative biopharmaceutical company dedicated to identifying, developing, and commercializing novel treatment options for patients with rare diseases. With an emphasis on Central Nervous System (CNS) disorders, our goal is to push the boundaries of what science can do to improve the lives of patients.  Our primary mission is to have a positive impact on the lives of those who are so often underserved. We believe it takes both scientific vision and tenacity to pursue new therapies that will have the potential to transform the lives of patients.

 


    Incyte Corporation

 
www.incyte.com

Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics, primarily for oncology. The company’s first commercial product, Jakafi® (ruxolitinib), an oral JAK1 and JAK2 inhibitor, is approved by the FDA to treat two rare blood disorders--first approved in November 2011 Jakafi received a subsequent U.S. approval in December 2014. To learn about Jakafi, please visit www.Jakafi.com
 


    Indivior - Corporate Member Plus

 
www.indivior.com

Intarcia Therapeutics, Inc., is a rapidly emerging biopharmaceutical company developing innovative therapies that merge medicine with technology, and have the potential to transform therapeutic categories. Our near-term goal is to enhance treatment outcomes for patients with type 2 diabetes by improving efficacy, continuous administration, and tolerability of drug therapies.
 
 

    Insmed Incorporated

 
www.insmed.com

Insmed Incorporated (Nasdaq:INSM) is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. The Company is dedicated to developing and bringing to market novel, transformational therapies that make a real difference to patients. The Company’s lead product candidate is ALIS, which is in late-state development for adult patients with treatment-refractory NTM lung disease caused by MAC, a rare and serious disorder that can cause irreversible lung damage and can be fatal. 


    Ipsen Biopharmaceuticals - Corporate Member Plus

 
www.ipsen.com

Ipsen is a leading  biopharmaceutical group  dedicated to improving lives through innovative medicines in oncology , neuroscience  and rare diseases.  Ipsen’s mission, “innovation for patient care”, highlights the Group’s determination to focus on patients and unmet medical needs and to provide innovative therapeutic solutions.  As well as our dedication to improving the lives of patients, Ipsen is also firmly committed to protecting the environment and to supporting civil society and the communities in which we operate. The Group is pledged to promote ethical, responsible and transparent professional practices.
 


    Intercept Pharmaceuticals

 
www.interceptpharma.com

Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat chronic liver diseases utilizing our proprietary bile acid chemistry. The advances we are making in the development of novel treatments for liver diseases such as primary biliary cirrhosis (PBC) and nonalcoholic steatohepatitis (NASH) have the potential to change the lives of patients and physicians who currently have few, if any, therapeutic options.
 


    Johnson & Johnson Health Care Companies - Corporate Member Plus

 
www.jnj.com

Johnson & Johnson Health Care Companies are committed to creating measurable value for our managed markets customer through a dedicated focus on meeting your needs. In doing so, we will draw on our wide range of innovative products and services. We can work together to improve your clinical and business outcomes.
 


    Kroger Prescription Plans

 
  www.kpp-rx.com

Kroger Prescription Plans has provided comprehensive Pharmacy Benefits Management services since 1993. We combine transparency and highly competitive pricing to drive lower costs for clients and their members, while at the same time delivering exceptional customer service. Our plans are flexible and adaptable.  Kroger Prescription Plans is focused on improving the health & wellness of our customers. We are committed to advancing health, reducing costs and improving the efficacy of any client’s health strategy.

 


   Lexicon Pharmaceuticals

 
www.lexgen.com

Lexicon Pharmaceuticals is a biopharmaceutical company focused on the development of breakthrough treatments for human disease. We have advanced multiple drug candidates into clinical development. We are presently devoting most of our resources to the development of our two most advanced drug candidates, LX4211 for the treatment of type 1 and type 2 diabetes and Telotristat etiprate (LX1032/LX1606) for the treatment of carcinoid syndrome.
 


   Lilly USA, LLC

 
www.lilly.com

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquarted in Indianapolis, IN, Lilly provides answers – through medicines and information – for some of the world’s most urgent medical needs.
 


   Magellan Rx Management

 
www.magellanrx.com

At Magellan Rx Management, we are a full-service pharmacy benefits manager (PBM) that specializes in solving complex pharmacy challenges for our customers. We believe in developing and executing smart solutions that leverage our industry-leading experience and technology to exceed expectations across the following lines of business: Employer, Third Party Administrator, Broker; Managed Care; Government, Medicaid, Medicare Part D. As a pioneer in medical specialty pharmacy management and a leader in best-in-class formulary optimization programs, we deliver consistent, proven cost savings. As clinical experts, we deliver customized programs to address our clients’ most pressing clinical challenges, drive STAR improvements, and engage patients and providers to deliver improved health outcomes. elcome to a unique vision of care. Magellan Rx Management is a division of Magellan Health, Inc.
 


   Mallinckrodt

 
www.mallinckrodt.com

Mallinckrodt is a global specialty pharmaceutical company. Focus areas include therapeutic drugs for autoimmune and rare-disease specialty areas along with analgesics and central nervous system drugs for prescribing by office- and hospital-based physicians. Mallinckrodt’s Specialty Pharmaceuticals segment includes branded and specialty generic drugs and active pharmaceutical ingredients.
 


   MHK

 
www.mhk.com

MHK’s mission is to drive better member care in a changing healthcare environment by bringing every care moment in a person’s health journey together through an integrated platform.  Founded in 2010 on the concept that healthcare reimbursements would be tied to quality versus fee-for-service—a precursor to today’s value-based healthcare, MHK continues to push the envelope to ensure increased efficiencies that save time and money, and ultimately, enhance health outcomes.  Our vision is to build the trusted care management solutions of tomorrow to revolutionize the way healthcare is delivered. 


   MedImpact Healthcare Systems, Inc.

 
www.medimpact.com

MedImpact Healthcare Systems, Inc. (http://www.medimpact.com), founded in 1989 and headquartered in San Diego, Calif., is a full-service pharmacy benefit management (PBM) company that combines subject matter expertise with innovative technology and services to deliver better healthcare outcomes and improve its clients’ positions in the market. MedImpact provides PBM services to 47 million members of health plans, hospitals and employers in the U.S. and abroad. MedImpact’s model is unique: avoiding conflict of interest by deriving revenue from effectively managing client pharmacy benefits rather than dispensing drugs.
 


    Melinta Therapeutics - Corporate Member Plus

 
  www.melinta.com

Our mission is to meet the continually evolving threat of bacterial infections by discovering, developing, and commercializing a continual stream of novel antibiotics.  The introduction of antibiotics nearly 100 years ago was and remains one of the most transformative advances of medicine and public health, and was followed by a prolific stream of new antibiotics, representing a variety of different antibacterial target classes, for the next several decades. However, since the early 2000’s, few new antibiotics have been introduced, a consequence of a dramatic decrease in investment by the pharmaceutical industry in antibiotic research and development.
 


   Merck & Co., Inc.

 
www.merck.com

Today's Merck is a global healthcare leader working to help the world be well. Merck is known as MSD outside the United States and Canada. Through our prescription medicines, vaccines, biologic therapies, and consumer care and animal health products, we work wtih customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to healthcare through far-reaching policies, programs and partnerships. For more information, visit www.merck.com.
 


   Merz North America

 
www.merz.com

Merz North America is a specialty healthcare company that develops and commercializes innovative treatment solutions in aesthetics, dermatology and neurology in the U.S. and Canada. Our ambition is to become a recognized leader in the treatment of movement disorders, and in aesthetics and dermatology. Our future is promising, and we are committed to advancing new therapeutic options and improving patients’ lives. For more than 100 years, the development of our products has been based on Merz‘s commitment to providing innovative medical approaches that earn trust of patients, physicians and partners worldwide. Globally, the companies of Merz Pharma Group are focused on medications for treating neurological and psychiatric illnesses, and they have assumed a leading role in the field of Alzheimer’s disease research. Founded in 1908, Merz Pharma Group is a privately owned company headquartered in Frankfurt, Germany.
 


   Mirixa Corporation

 
www.mirixa.com

Mirixa Corporation is a leading healthcare technology and services company. Mirixa identifies and connects patients with trusted pharmacists and other healthcare providers for individualized medication counseling. Mirixa’s innovative technology and services improve patients’ health and reduce costs.
 


    Mylan Inc.

 
www.mylan.com

Mylan is one of the world’s leading generics and specialty pharmaceutical companies, providing products to customers in more than 150 countries and territories. The company maintains one of the industry’s broadest and highest quality product portfolios, which is regularly bolstered by an innovative and robust product pipeline.
 


    Myriad

 
  www.myriad.com

Since 1991, Myriad has invested heavily in educating patients and healthcare professionals about the role genes and proteins play in disease. More than 1.5 million patients have already benefited from Myriad’s hereditary cancer genetic testing, which helps healthcare professionals better manage and tailor medical care.  Today, Myriad continues this strong tradition. We are expanding our reach and increasing our impact on patient care by introducing new molecular diagnostic and companion diagnostic tests for a growing number of diseases.

 
 

   NaviSync, LLC

 
www.navisyncllc.com

The health care environment is becoming more complex, with commercial and government payers attempting to control how health care is practiced and influence market perceptions about products, coverage, or services. NaviSync is a full-service managed markets company providing intelligent sound strategy to increase access to your brand through the utilization of actionable insights gleaned from payers, hospitals, and alternative care settings. Efficiently delivered market intelligence is critical to attaining payer access and achieving commercial success. We tackle access and reimbursement challenges for top-tier pharmaceutical/biotechnology companies, including specialty market products.
 
 

   Neurelis

  
www.neurelis.com

Neurelis is a unique company focused on therapies for disorders involving the central nervous system. Our company is built on a foundation of passion and progress. This passion fuels our drive to successfully deliver innovative therapies that have the potential to change the lives of patients, caregivers, and healthcare providers.  Neurelis is a neuroscience-based specialty pharmaceutical company dedicated to enhancing therapeutic benefit and addressing unmet needs in patient care.

 


   NovaBay Pharmaceuticals

 
www.novabay.com

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company developing products for the eye care market. We are currently focused primarily on commercializing prescription Avenova® for managing hygiene of the eyelids and lashes in the United States. Avenova is the only eye care product formulated with a proprietary, stable and pure form of hypochlorous acid called Neutrox®. By replicating the anti-microbial chemicals used by white blood cells to fight infection, Neutrox has proven in laboratory testing to have broad antimicrobial properties. In addition to our Neutrox family of products, we have also synthesized and developed a second category of novel compounds aimed at harnessing the power of white blood cell chemistry to address the global, topical anti-infective market. This second product category includes auriclosene, our lead clinical-stage Aganocide® compound, which is a patented, synthetic molecule with a broad spectrum of activity against bacteria, viruses and fungi.
 


   Novartis Pharmaceuticals Corporation

 
www.novartis.com

Novartis Pharmaceuticals Corporation is committed to improving health and quality of life by focusing on the discovery, development, manufacture and marketing of innovative, effective and safe prescription medications. Key therapeutic areas include Cardiovascular, Endocrine & Respiratory Diseases, Gastroenterology; Central Nervous System Disorders; Dermatology; Oncology/Hematology; Rheumatism/Bone & Hormone Replacement Therapy and Transplantation. Located in East Hanover, NJ, Novartis Pharmaceuticals is an affiliate of Novartis AG, a world leader in Healthcare in more than 140 countries with core businesses in pharmaceuticals, consumer health, generics, eyecare, and animal health.
 


   Novo Nordisk, Inc. - Platinum Corporate Member

 
www.novonordisk-us.com

Novo Nordisk Inc. is a focused healthcare company. With a broad diabetes product portfolio, including innovative products within the area of insulin delivery systems, Novo Nordisk is a world leader in diabetes care. Novo Nordisk manufactures and markets pharmaceutical products and services that make a significant difference to patients, the medical profession, and society. Worldwide, Novo Nordisk employs an estimated 18,800 people in 69 countries and markets its products in 179 countries. Novo Nordisk's global headquarters is located in Denmark where the company began more than 80 years ago with the North American affiliate headquartered in Princeton, NJ.
 


   Optinose, Inc.

  
 www.optinose.com

The Optinose team is unified by a common shared mission: to improve lives. We will accomplish this while creating value for investors and the healthcare system along with better outcomes for patients and providers. As innovators in every aspect of our work, we will pursue faster and less costly product development, explore evolving commercial business models, and actively seek innovative ways to be more effective and efficient. We are committed to working together as a team that chooses to live every day by core company values that guide our daily behaviors, creating a foundation for future success.
 


   OptumRX

 
www.optumrx.com

OptumRx® is a pharmacy care services company with a flexible and innovative approach. Our combined company now connects more than 65 million Americans to improved care, lower costs and a better health care experience. Most traditional PBMs focus on distributing prescriptions and managing pharmacy costs. Our diverse and unique resources enable OptumRx to go beyond the prescription — and help our customers and members reduce total health care costs and improve health.
 
 

   Paratek

  
  www.paratekpharma.com

At Paratek, solutions are provided that enable positive outcomes and lead to positive patient stories. Paratek Pharmaceuticals is a biopharmaceutical company that develops transformative solutions for patients, both in and out of the hospital, with diseases that are not responsive to current treatments.  We focus on drugs that target infectious disease and other difficult to treat conditions.
 


   PerformRx

 
www.performrx.com

PerformRx, LLC provides innovative, cost-effective pharmacy benefit management services for Medicaid, Medicare, and commercial health plans. Through a distinctive, hightouch approach, PerformRx partners with health plans to improve patient outcomes and financial performance. PerformRx bases its success on a clinical focus hat is driven by cutting edge, proprietary technology.
 


   Pfizer Inc.

 
www.pfizer.com

As one of the world’s leading healthcare companies, Pfizer has developed and brought to market medicines for humans and animals for over 150 years. Our portfolio includes more category-leading medicines than any other company – treatments that are helping countless people everyday to ease arthritis and nerve pain, manage depression, fight diabetes and cancer and control hypertension. Our portfolio of innovative medicines currently includes treatments for more than a dozen disease areas and we are targeting unmet medical needs through state-of-the-art research and development. We know that healthcare is more than a business—it’s a mission-and our products can only help people if they can get them. That’s why we are deeply committed to enhancing access to high-quality healthcare. This year, through innovative partnership programs, Pfizer is giving product donations for patients in need around the world and building the infrastructure necessary to ensure that the medicines get to those who need it most. The value of medicine. The benefits of research. The commitment to help meet the needs of those in need. At Pfizer, we dedicate ourselves to humanity’s quest for longer, healthier, happier lives through innovation in pharmaceutical, consumer and animal health products.
 


   Pharmacy Quality Solutions, Inc.

 
 www.pharmacyquality.com

Who We Are Pharmacy Quality Solutions, Inc. (PQS) is a joint venture created to fill the need to connect medication use stakeholders to quality information in a consistent and reliable fashion, allowing them to move more quickly from measurement to improvement. Our hallmark service is EQuIPP, the first national pharmacy quality measurement, benchmarking, and reporting platform for pharmacies and health plans. EQuIPP provides consistent and reliable measurement and reporting on key medication use quality measures, including those addressing medication adherence and patient safety, and makes this measurement available and easily understandable.
 


   Precision for Value

 
www.precisionforvalue.com

-Precision for Medicine, headquartered in Bethesda, MD, is a specialized company providing services and infrastructure to support life sciences companies as they develop new products in the age of precision medicine. Precision brings expertise, technology, and project execution to support innovative, patient-centric solutions from discovery through commercialization. www.precisionformedicine.com
-Precision for Value supports commercial excellence for global pharmaceutical and life sciences clients through the proficient demonstration of product value and outcomes. With locations in New York City, New Jersey, Chicago, Boston, Connecticut, and Indianapolis, Precision for Value’s teams provide clients with services grounded in decades of industry knowledge, demonstrated analytics proficiency, and marketing and communications prowess—making Precision for Value the preferred strategic partner in the industry. www.precisionforvalue.com
-Precision Advisors combines unrivaled real-world market experience with thought leadership and industry expertise to provide insight, strategy and advice to innovative life science companies. Headquartered in Cambridge, Massachusetts, Precision Advisors’ unmatched team of expert advisors encompass all areas of the commercialization spectrum including strategy consulting, managed markets, health economics, clinical research and analytics. www.pfmadvisors.com
-Precision for Medicine, headquartered in Bethesda, MD, is a specialized company providing services and infrastructure to support life sciences companies as they develop new products in the age of precision medicine. Precision brings expertise, technology, and project execution to support innovative, patient-centric solutions from discovery through commercialization. www.precisionformedicine.com"
 


   Prime Therapeutics LLC

 
www.primetherapeutics.com

Prime Therapeutics is an independent pharmacy benefit manager that is committed to the health of those we serve. Our "people over profits" approach reflects our privately held heritage. We also believe it produces the best results. Our health care system is fragmented. Instead of working together, doctors, pharmacists, and insurers often focus only on their own pieces of the puzzle. Poor communication and lack of coordination cause errors and create gaps in care. Prime has a different view. Because we are collectively owned by non-profit health plans, we never forget that drugs are part of a bigger picture. We exchange pertinent data and insights with health plans and work with them to coordinate across pharmacy and medical benefits. We leverage our unique connections to deliver programs that lead to the best health outcomes.
 


   Promius

  
http://promiuspharma.com

Promius Pharma designs personal and practical health care solutions for people. Through robust dialogue with patients and health care providers, we understand and try to address the most important unmet needs by creating tailored solutions to help people better manage disease.

We collaborate to identify proven molecules and find new ways to improve their delivery and enhance their value. By making the right investments in Research and Development, Promius Pharma efficiently navigates regulatory pathways to be faster to market.

 
 


   Purdue Pharma, L.P.

 
www.pharma.com

Purdue Pharma L.P. develops and provides prescription medicines that meet the evolving needs of healthcare professionals, patients, and caregivers.  We were founded by physicians and we are currently led by a physician.  Beyond our efforts to provide quality medications.  Purdue is committed to supporting national, regional and local collaborations to drive innovations in patient care. Privately held, Purdue is pursuing a pipeline of new medications and technologies through internal research & development and strategic industry partnerships.
 


   Relypsa, Inc. - Corporate Member PLUS

 
www.relypsa.com

Relypsa is a biopharmaceutical company leading the discovery, development and commercialization of polymer-based medicines to treat conditions that are often overlooked and undertreated, but that can have a serious impact on patient lives or even be life-threatening.  We are focused on developing medicines that will change treatment paradigm and work to improve patient lives through discovery, development and delivery of therapeutics that leverage polymer science and other novel approaches.


   RTI Health Solutions

  
 www.rti.org

Over more than 55 years, RTI International has earned a reputation for high-quality research and technical services that deliver exceptional value to our clients. We provide our clients with independent, objective, science-based solutions that are tailored to meet their requirements.  We achieve these high standards through teamwork, innovation, and attention to detail, and by striving for continuous improvement in our products and services. At RTI, quality efforts are overseen by a steering committee comprising senior leaders from across our organization and backed up by a set of policies, procedures, and processes designed to ensure compliance.  An important aspect of our quality program at RTI is working with our clients to define their needs and clarify expectations. With this information, we are able to tailor our solutions to meet cost and time constraints.


   RxAdvance

 
www.rxadvance.com

RxAdvance is a national full service PBM (Pharmacy Benefit Manager), bringing superior clinical, pharmacy, and financial outcomes to plan sponsors through Collaborative PBM Cloud. Built on a unified data model and clinical intelligence, RxAdvance’s PBM standard services include Benefit and Formulary Design, Claims Processing, Customer Support Services, Retail Pharmacy Network Management, Clinical Services, and Rebate Management. Our market differentiation includes Drug Utilization Review at Point of Care (PoC) and Point of Sale (PoS), Medication Therapy (MTM) and Adherence Management (MAM), Donut Hole Prediction and Prescription Planner, Optimize Untapped Generics Usage, Prevent Adverse Drug Effects, Fraud, Waste and Abuse Management, Advanced Analytics and Cost Management, Maximize Mail Order Services, and Effective Specialty Management. RxAdvance enables real-time actionable communication between prescriber, pharmacist, patient, and payer. Our best in class People, Process and Technology are for all plan sponsors—health plans, Accountable Care Organizations (ACOs), state Medicaid programs, employer groups, and unions. We provide contractually guaranteed savings in administrative costs, unit costs, and rebate revenues.
 


   Sage Therapeutics

 
www.sagerx.com

Sage Therapeutics is a clinical-stage biopharmaceutical company committed to developing novel medicines to transform the lives of patients with life-altering central nervous system (CNS) disorders.  Sage is thinking differently about drug development by using a focused, practical and deliberate approach. We responsibly pursue expedited pathways in our efforts to deliver new treatments for CNS disorders. At Sage, our mission is to make life better for patients with CNS diseases by discovering, developing, and delivering important new medicines for patients in need.


   Sandoz - Platinum Corporate Member 

 
www.sandoz.com

Sandoz is a world leader in generic pharmaceuticals, finding innovative ways to making medicines affordable and accessible to more than 90 percent of the world’s population.Sandoz prides itself on thinking differently. While developing and manufacturing high-quality affordable medicines is core to who we are and what we do, our mission is even greater: We endeavor to make these medicines available to everyone, everywhere. Our portfolio of approximately 1 100 molecules is already available to more than 90% of the world’s population and we continue to work hard to further increase global access. 
 


   Sanofi

 
www.sanofi.com

Life is a health journey, with ups and downs, which can be big or small, lifelong or momentary.  We, at Sanofi, are there for those challenges, by the side of people as a health journey partner.  We believe that empowering individuals, the community and healthcare professionals to promote and practice self-care, will lead to people all over the world being healthier. Our self-care solutions cover cough and cold, allergies, digestive health, nutritionals and pain care.  With the development of more sedentary lifestyles, diabetes and cardiovascular diseases have become global public health issues. As a journey partner, our purpose is to help people with diabetes and cardiovascular diseases improve their quality of life.  We have a strong heritage in oncology and are committed to finding new pathways to treat people affected by the disease and improve their quality of life. We, at Sanofi, believe that open innovation will help develop new approaches and expertise to discover targeted treatments against cancer. 

 

   Seattle Genetics

  
 www.seagen.com

Seattle Genetics is the largest global oncology biotechnology company based in the Pacific Northwest. We are focused on developing and commercializing a new generation of targeted, empowered antibody-based therapies that have the potential to change the foundation of treatment for people with cancer.  Our industry-leading antibody-drug conjugate (ADC) technology combines the specificity of monoclonal antibodies, innovative linker systems, and the power of potent cell-killing agents to treat cancer. Using our proprietary technology, we are able to optimize each ADC to potentially improve outcomes for patients. ADCs are an integral part of the evolving cancer treatment paradigm with their specificity, stability and potency.
 


   Shionogi Inc.

  
www.shionogi.com

More than 23,000 men, women, and children in the U.S. die every year from antibiotic-resistant infections while over 4,000 Americans perish from influenza. In addition, over 100 million suffer from chronic pain and 3.9 million adults in the U.S. are diagnosed with liver disease. Shionogi's mission is to supply the best possible medicines to protect the health and well-being of the patients we serve.

 
 

   Sobi - Corporate Member Plus

 
www.sobi.com 

Sobi is an international rare disease company dedicated to providing access to innovative treatments that make a significant difference for people with rare diseases.  Strong and growing portfolio:  We have two busienss areas: Haemophilia and Specialty Care.  Our research and product portfolio is primarily focused on hemophilia, inflammation, and genetic and metabolic diseases.  In Hemophilia, we aim to take a leadership position.  Sobi is an integraterd biotechnology company with in-house capabilities that encompass the entire value chain, from research to preclinical and clinical development, biologis manufacturing and supply, to patient access and distribution.  This integrated approach is a prerequisite for providing proprietary drugs, and an enabler for partnerships, especially at early stages of drug development. 

 

   Sunovion

 
www.sunovion.com

At Sunovion, patients are at the center of everything we do.  We are creating innovative psychiatric, neurological and respiratory therapies that help transform people's lives, while at the same time we are playing an increasingly active role in the future of global health. Our Mission is to broadly contribute to society through value creation based on innovative research and development activities for the betterment of health care and fuller lives of people worldwide. Our Vision is to lead the way to a healthier world and Our Values are to serve and create value for patients; act with the highest standards; trust and empower our people; align, collaborate and win as one team.

 
   


   Supernus Pharmaceuticals Inc.

 
www.supernus.com

With more than 20 years of experience, we are a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) disorders. We are developing several product candidates in neurology and psychiatry to address unmet medical needs and opportunities in epilepsy, attention-deficit hyperactivity disorder (ADHD) and its coexisting disorders, and depression. We are developing differentiated products by leveraging our proprietary and in-licensed technologies. We use such technologies to discover and develop novel uses for known drug compounds and to enhance their therapeutic benefits. Our focus on known drug compounds with established mechanisms of action reduces the risks, costs, and time typically associated with pharmaceutical product development.
 


   Taiho Oncology, Inc.

 
www.taihooncology.com

Taiho Oncology, Inc. (www.taihooncology.com), a division of Taiho Pharmaceutical Co., Ltd. and Otsuka Holdings Co., Ltd., has built a world class clinical development organization that works urgently to develop innovative cancer treatments and is in the process of building commercial businesses in the USA and Europe. Taiho’s oral oncology pipeline consists of both novel antimetabolic agents and selectively targeted agents.
 


   Takeda Pharmaceuticals U.S.A., Inc. - Platinum Corporate Member 

 
www.takeda.us

Based in Deerfield, IL, Takeda Pharmaceuticals, U.S.A., Inc and Takeda Development Center Americas, Inc. are subsidiaries of Takeda Pharmaceutical Company Limited, the largest pharmaceutical company in Japan. The respective companies currently market oral diabetes, respiratory and immunology, gastroenterology, central nervous system and obesity treatments and seek to bring innovative products to patients through a pipeline that includes compounds in development for metabolic and cardiovascular disease, central nervous system, oncology and other conditions. To learn more about Takeda companies and products, visit www.takeda.com.
 


   Teva Pharmaceuticals

 
www.tevausa.com

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Headquartered in Israel, Teva is the world's leading generic drug maker, with a global product portfolio of more than 1,000 molecules, sold in more than 100 countries, and with a direct presence in about 60 countries. Teva's specialty medicine businesses focus on CNS, including pain, respiratory, oncology, and women's health therapeutic areas as well as biologics. Teva currently employs approximately 45,000 people around the world and reached $20.3 billion in net revenues in 2013.
 


   TOLMAR Pharmaceuticals Inc.

 
www.tolmar.com

TOLMAR is a fully integrated company focused on the development, approval, and commercialization of specialty pharmaceutical products, including a line of generic dermatology products where TOLMAR is an established leader, and specialty injectable oncology products. Invention, development, and worldwide approval of ELIGARD® (leuprolide acetate for injectable suspension) for the palliative treatment of advanced prostate cancer has established TOLMAR as a leader dedicated to the urology community, providers, and patients. TOLMAR has 24 FDA-approved products.
 
 

   UCB 

 
 www.ucb.com

UCB's ambition is to transform the lives of people living with severe diseases.  We focus on neurology and immunology disorders - putting patients at the center of our world.  We are Inspired by Patients.  Driven Bey Science.  UCB is continuously working to advance science and embrace new knowledge.  We are leveraging scientific advances and skills in areas such as genetics, biomarkers and human biology.  Patients inspire us to bring them value through cutting-edge science, innovative drugs, and practical solutions - so that they and their carers can get on with their lives.

 


   Upsher-Smith Laboratories, LLC.

 
www.upsher-smith.com

Upsher-Smith Laboratories, Inc., founded in 1919, is a growing, fully integrated pharmaceutical company dedicated to its mission of delivering high-value, high-quality therapies and solutions which measurably improve individuals’ lives. As a family-owned pharmaceutical company, we are able to adapt and thrive in a dynamic healthcare environment. Our world is constantly evolving, and we are continually adapting to the ever-changing needs of patients, physicians, pharmacists, and healthcare organizations. Where there is a need, we will work to deliver solutions that simplify access to treatment, deliver better health outcomes, and enhance life. Upsher-Smith has a particular focus on developing therapies for people living with central nervous system (CNS) conditions, such as seizure disorders. For more information, visit www.upsher-smith.com.
 
 

  Xcenda

 
 www.amerisourcebergen.com

Xcenda is a premier full-service consultancy and leading managed markets agency whose experienced consulting team helps manufacturers identify, demonstrate, and deliver their brand’s value proposition to all healthcare stakeholders. For 15 years, Xcenda has been an essential partner, offering both strategic guidance and field support, to global pharmaceutical, device, and diagnostic companies, as well as emerging pre-commercialization phase firms. Clients who partner with Xcenda access marketers, health outcomes researchers, epidemiologists, reimbursement strategists, market research experts, managed care decision makers, and clinicians who bring a breadth of expertise across payer, provider, and patient segments. In addition, as Xcenda is part of AmerisourceBergen Corporation, our clients benefit from greater access to an integrated and comprehensive range of specialty distribution and commercialization support services. 
 

As of April 2019